Cargando…
Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors
In the range of clinical decision points for response-guided therapy of HCV, there is still insufficient data concerning the conformity of quantification results obtained by different assays and their correlation with the HPS/CTM v2 assay which was used for initial clinical studies. In a head-to-hea...
Autores principales: | Wiesmann, F., Naeth, G., Sarrazin, C., Berger, A., Kaiser, R., Ehret, R., Knechten, H., Braun, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514908/ https://www.ncbi.nlm.nih.gov/pubmed/25398515 http://dx.doi.org/10.1007/s00430-014-0364-z |
Ejemplares similares
-
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
por: Wiesmann, F., et al.
Publicado: (2015) -
Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019) -
Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis
por: Tang, Weiming, et al.
Publicado: (2022) -
Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
por: Czarnecka, Paulina, et al.
Publicado: (2022) -
Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
por: Eckman, Mark H., et al.
Publicado: (2021)